https://scholars.lib.ntu.edu.tw/handle/123456789/558313
標題: | Dementia risk in type 2 diabetes patients: Acarbose use and its joint effects with metformin and pioglitazone | 作者: | CHIN-HSIAO TSENG | 關鍵字: | Acarbose; Dementia; Diabetes mellitus; Metformin; Pioglitazone; Taiwan | 公開日期: | 2020 | 出版社: | International Society on Aging and Disease | 卷: | 11 | 期: | 3 | 起(迄)頁: | 658-667 | 來源出版物: | Aging and Disease | 摘要: | This population-based retrospective cohort study investigated dementia risk associated with acarbose in patients with type 2 diabetes mellitus by using Taiwan's National Health Insurance database. A cohort of 15,524 matched pairs of ever and never users of acarbose based on propensity score matching was enrolled from new-onset type 2 diabetes patients from 1999 to 2006. Patients who were alive on January 1, 2007, were followed up for dementia until December 31, 2011. Adjusted hazard ratios were estimated using Cox proportional hazards models. The results revealed that the incident case numbers (incidence rates) of dementia were 264 (407.19 per 100,000 person-years) for never users and 231 (337.94 per 100,000 person-years) for ever users. The hazard ratio for ever users versus never users was 0.841 (95% confidence interval, 0.704-1.005) and 0.918 (0.845-0.998) for every 1-year increment of cumulative duration of acarbose therapy. Subgroup analyses showed that the reduced risk associated with acarbose was only observed in women (adjusted hazard ratio, 0.783; 95% confidence interval, 0.618-0.992) and in non-users of metformin (adjusted hazard ratio, 0.635; 95% confidence interval, 0.481-0.837). A model comparing different combinations of acarbose, metformin, and pioglitazone suggested that users of all three drugs had the lowest risk of dementia (hazard ratio, 0.406; 95% confidence interval, 0.178-0.925). In conclusion, reduced risk of dementia associated with acarbose is observed in the female sex and in non-users of metformin. Moreover, users of all three drugs (acarbose, metformin, and pioglitazone) have the lowest risk of dementia. ? 2019 Tseng CH. |
URI: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85086367434&doi=10.14336%2fAD.2019.0621&partnerID=40&md5=809662bfdff1798a59141534bc45c562 https://scholars.lib.ntu.edu.tw/handle/123456789/558313 |
ISSN: | 2152-5250 | DOI: | 10.14336/AD.2019.0621 | SDG/關鍵字: | acarbose; metformin; pioglitazone; adult; aged; cohort analysis; data base; dementia; diabetic patient; female; human; major clinical study; male; national health insurance; non insulin dependent diabetes mellitus; population research; retrospective study; Review; risk assessment; sex difference; Taiwan; treatment duration |
顯示於: | 醫學系 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。